Product Information
OXYBUTYNIN 5 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0473 per EA under NDC 64380078108. Its NADAC has been published 26 times since Jul 2, 2025.
Strength
5 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380078108
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208165On Market Since
12/20/2024
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN 5 MG TABLET has been published 26 times since Jul 2, 2025, and over the history we have for it it has declined 4.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0473 per EA |
|---|---|
| All-time high | $0.0505 (Aug 13, 2025) |
| All-time low | $0.0468 (Nov 19, 2025) |
| 52-week high | $0.0505 |
| 52-week low | $0.0468 |
| Median price | $0.0492 |
| Average price | $0.0490 |
| Largest weekly change | -3.2% (Nov 19, 2025) |
| Weeks tracked | 26 |
| Tracking since | Jul 2, 2025 |
Generic Alternatives
The matcher finds 13 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXYBUTYNIN 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN 5 MG TABLET, manufactured by Strides Pharma Inc., is $0.0473 per EA (NDC 64380078108), effective Jun 24, 2026.
How has the price of OXYBUTYNIN 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN 5 MG TABLET has declined 4.1%. It has been tracked across 26 weekly CMS publications since Jul 2, 2025.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN 5 MG TABLET?
Since Jul 2, 2025, the NADAC for OXYBUTYNIN 5 MG TABLET has ranged from a low of $0.0468 (Nov 19, 2025) to a high of $0.0505 (Aug 13, 2025), with a median of $0.0492 per EA.
Are there cheaper alternatives to OXYBUTYNIN 5 MG TABLET?
13 NADAC-published products share the same active ingredient, strength, and dosage form as OXYBUTYNIN 5 MG TABLET, but none are currently priced below it.
Who manufactures OXYBUTYNIN 5 MG TABLET?
OXYBUTYNIN 5 MG TABLET (NDC 64380078108) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification